CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
BioSuperior
BioSuperior logo

BioSuperior

BioSuperior: Innovating cost-effective biotherapies for lung disease repair using novel technology.

Los Altos, CA, US🇺🇸
Founded
2017
Overview
Compare
Fundraising
Employees
Library

BioSuperior, founded with a mission to revolutionize pulmonary care, is a preclinical stage biotherapeutics company focused on developing cost-effective, non-invasive, and accessible technologies to cure lung disease and repair damaged lung tissue. Their flagship product, BioSurf, is a novel synthetic pulmonary surfactant designed to restore normal lung function and deliver potent drugs directly to the lungs. BioSuperior aims to address the critical need for advanced treatments in respiratory health.

Notable figures affiliated with BioSuperior include leading scientists and industry experts in biotherapeutics and pulmonary medicine. The company has attracted attention from prominent investors in the biotech sector, recognizing its potential to significantly impact respiratory healthcare. Key achievements include the successful bio-engineering of BioSurf and promising preclinical results. BioSuperior's innovative approach holds the promise of transforming treatment paradigms for lung diseases, potentially improving outcomes for millions of patients worldwide.

BioSuperior - Similar Companies

Surf Bio logo

Surf Bio

surf.bio

Superior Biologics logo

Superior Biologics

Alveolus Bio logo

Alveolus Bio

alveolusbio.com

Lung Biotechnology logo

Lung Biotechnology

unither.com

Spyryx Biosciences logo

Spyryx Biosciences

Spirrow Therapeutics logo

Spirrow Therapeutics

Pulmatrix logo

Pulmatrix

pulmatrix.com

Pulmair Medical logo

Pulmair Medical

Synspira logo

Synspira

BioSurfaces logo

BioSurfaces

biosurfaces.us

Vero Biotech logo

Vero Biotech

vero-biotech.com

Peroxitech Therapeutics logo

Peroxitech Therapeutics

BioPlx logo

BioPlx

Respirogen logo

Respirogen

respirogen.com

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

BioSuperior - Quick Facts

Who are BioSuperior's competitors?

Companies similar to BioSuperior include Surf Bio, Superior Biologics, Alveolus Bio and Lung Biotechnology.

When was BioSuperior founded?

BioSuperior was founded in 2017.

Where is BioSuperior's headquarters located?

BioSuperior's headquarters is located in Los Altos, CA, US.

When was BioSuperior's last funding round?

BioSuperior's most recent funding round was for $256k (USD) in June 2022.

How much disclosed funding has BioSuperior raised?

As of Jun 17, 2022, BioSuperior has disclosed funding of $256k (USD). Undisclosed round amounts are excluded.

How many employees does BioSuperior have?

BioSuperior has 6 employees as of Feb 4, 2024.

BioSuperior - Classification

Ownership
  • Venture-backed
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotherapeutics
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 440000Retail Trade
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 5900Miscellaneous Retail
  • 5910Drug Stores And Proprietary Stores